Search NovaTechs

NovaSeal™
Interventional Radiology
Embolization

About NovaTechs

Leading the way in innovative interventional radiology through advanced gel-based solutions.

2008
Pioneering Hydrogel Research
2020
NovaTechs Established
2023
NovaSeal™ Launched

Our Story

NovaTechs BV was founded in 2020 in the Netherlands, driven by a passion for innovation and a commitment to improving drug delivery in oncology. Our research on hydrogels began in 2008, focusing on nano-pharmaceuticals and targeted therapeutics. This work led us to develop advanced delivery platforms like nanogels and in-situ gel systems. As we recognized a significant gap in interventional oncology, we shifted our focus to creating more effective and safer cancer treatments.

NovaTechs Foundation
NovaSeal Development

The Birth of NovaSeal™

In 2023, we launched NovaSeal™, our flagship liquid embolic agent aimed at transforming cancer treatment. Designed for targeted therapy, NovaSeal minimizes harm to healthy tissues while maximizing tumor impact. Its unique formulation uses bio-based materials, ensuring both efficacy and safety, and underscores our commitment to sustainability for patients and the planet.

Mission & Vision

Inspired by wisdom, driven by innovation

Our Mission

NovaTechs is dedicated to transforming the lives of cancer patients by enhancing health outcomes and quality of life through advanced, non-toxic, and less invasive pharmaceutical solutions. Our products meet the highest standards of quality and efficacy by bridging the gap between innovative ideas, scientific research, and practical applications.

Our Vision

Inspired by the wisdom of the great Iranian philosopher and physician, Avicenna, that "starving cancer cells is better than stabbing them," our vision is to block the blood supply to cancer cells using gel-based formulations. We strive to create a healthier future for communities worldwide by prioritizing patient needs and fostering a culture of innovation and collaboration.

Our Commitment

Founded on profound expertise and a deep sense of purpose, our unwavering commitment is to advance clinically relevant, sustainable, and user-friendly embolic solutions, making a significant impact in the battle with cancer.

Our Values

The principles that guide our innovation and growth

Innovation

Continuously pushing boundaries in medical technology to create breakthrough solutions.

Sustainability

Committed to environmental responsibility through bio-based materials and eco-friendly processes.

Collaboration

Building strong partnerships with academic institutions, healthcare providers, and industry leaders.

Safety

Prioritizing patient safety through rigorous testing and non-toxic formulations.

Excellence

Maintaining the highest standards in research, development, and product quality.

Compassion

Putting patients first and understanding the human impact of our innovations.